NEWS & INSIGHTS

KnowHow: The FDB Blog

Interoperability Blog Picture

EHR Interoperability Following in E-Prescribing's Footsteps?

Corporate Perspective, Standards, Government
Wednesday, December 10, 2014
by Tom Bizzaro, RPh

The current EHR interoperability movement could take a page or two out of the e-prescribing book. Read More

Pill Bottles

2014 Update: Demystifying Source NDC Codes, Repackaged Products and Biosimilars

Corporate Perspective, FDA, Standards
Thursday, October 23, 2014
by Julie Suko, PharmD

It’s time for the 2014 update to what the FDB marketing department informs me on a regular basis is the most popular FDB blog topic of all time. Read More

Rising Tide

Are You Prepared to Meet the Rising Tide of Boxed Warning Drugs?

Corporate Perspective
Tuesday, September 23, 2014
by Christine Cheng, PharmD

What do antidepressants, antipsychotic drugs, smoking cessation agents, non-steroidal anti-inflammatory drugs (NSAIDs) have in common? All of these drugs have the FDA’s highest warning: the boxed warning. Read More

Welcome to Drug Knowledge

Brand

What if drug data was more than just data? > Visit the Media Centre for more videos.

Media Centre >